Welcome to our dedicated page for Adtalem Global Ed SEC filings (Ticker: ATGE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Covista Inc. SEC filings document the company’s transition from Adtalem Global Education Inc. and its ongoing disclosures as a healthcare education company. Recent 8-K filings cover certificate and bylaw amendments for the name change, the related ticker change from ATGE to CVSA, academic and financial results, enrollment trends, guidance updates, and Regulation FD investor materials.
The filings also describe capital-structure and governance matters, including credit agreement amendments, term loan refinancing, senior secured notes redemption, share repurchase authorizations, and annual meeting vote results. These records frame the company’s public-company reporting around healthcare education operations, institutional performance, capital allocation, debt arrangements, and shareholder governance.
Adtalem Global Education Inc. filed a current report to note it has released its second quarter fiscal 2026 academic, operating and financial results. The company states these results in a separate press release dated January 28, 2026, which is attached as an exhibit.
The filing also includes a standard caution that certain statements about future growth and other expectations are forward-looking and subject to risks and uncertainties, referring readers to the company’s most recent annual report and other SEC filings for detailed risk factors.
Dimensional Fund Advisors LP filed an updated ownership report on Adtalem Global Education Inc, showing beneficial ownership of 1,766,448 shares of common stock, or 4.9% of the class, as of December 31, 2025. Dimensional reports sole power to vote 1,708,304 shares and sole power to dispose of 1,766,448 shares, with no shared voting or dispositive power.
The shares are held across various funds and accounts it advises, and Dimensional disclaims beneficial ownership beyond what is required for Section 13(d) reporting. It also certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Adtalem.
Adtalem Global Education Inc. reported that its Board of Directors has authorized the repurchase of up to an additional $750 million of its common stock. The company may buy shares over time through open market purchases, accelerated share repurchases, privately negotiated deals or other methods, in line with Rule 10b-18 and subject to market conditions, through the period ending December 15, 2028.
Adtalem also announced that it has completed its prior share repurchase program, under which it repurchased $150 million of its shares. The company noted that the new authorization does not require it to repurchase a specific number of shares and can be suspended, modified or terminated at any time without prior notice.
Adtalem Global Education Inc.'s Chairman and CEO reported a charitable stock gift. On 12/10/2025, he transferred 5,332 shares of Adtalem common stock as a gift, with a reported transaction price of $0. Following this donation, he beneficially owned 445,198 shares directly. This filing is a routine insider ownership update and does not reflect a market sale.
Adtalem Global Education reported final results from its Annual Meeting of Shareholders held on November 12, 2025. Shareholders voted on director nominees and other proposals, with detailed tallies disclosed.
For director nominees, “For” votes ranged from 30,915,164 (Stephen W. Beard) to 31,742,972 (Kenneth J. Phelan). Each nominee’s “Against” votes were under 820,000, with broker non‑votes of 1,443,088 recorded for all director items.
Additional proposals received the following totals: 32,536,515 For, 627,124 Against, and 78,017 Abstain; and 27,143,411 For, 4,326,428 Against, 328,729 Abstain, with 1,443,088 broker non‑votes.
Adtalem Global Education (ATGE) — Form 4 insider activity: A director was granted 1,445 restricted stock units on 11/12/2025. The award size was based on dividing the director compensation by $96.86, the ATGE closing price on that date, and these units vest 100% one year from the grant. On 11/13/2025, 645 shares were withheld to satisfy tax obligations upon the vesting of previously awarded RSUs. Following these transactions, the director beneficially owns 44,251 common shares directly.
Adtalem Global Education (ATGE) reported insider activity by a director. On November 12, 2025, the director acquired 1,445 restricted stock units (RSUs) at a reference price of $96.86. These RSUs vest 100% one year after the grant date.
On November 13, 2025, 421 shares were withheld to satisfy tax obligations at $96.26 (Transaction Code F). Following these transactions, the director directly owns 2,584 shares.
Adtalem Global Education (ATGE) Form 4: Company officer (President, Adtalem Elevate) reported equity movements. On 11/12/2025, the insider received 1,673 restricted stock units, which convert one-for-one into common shares and vest in three equal installments beginning on November 12, 2026, recorded at $96.86. On 11/13/2025, 355 shares were withheld at $96.26 to satisfy taxes upon the vesting of previously awarded RSUs.
Following these transactions, the insider reports 24,134 shares beneficially owned, held directly.
Adtalem Global Education (ATGE) Form 4: the company’s Chief Financial Officer, Mr. Phelan, reported equity award activity. On 11/12/2025, 4,259 restricted stock units (RSUs) were acquired at a reported price of $96.86. These RSUs convert one-for-one into common shares and vest in three equal installments beginning on November 12, 2026.
On 11/13/2025, 623 shares were disposed of under code “F” at $96.26, representing shares withheld to satisfy tax obligations upon a prior RSU vesting. Following these transactions, the officer directly beneficially owns 65,806 common shares.
Adtalem Global Education (ATGE) reported insider activity via Form 4. On November 12, 2025, a director received 1,445 restricted stock units (RSUs), with the grant size determined using the $96.86 closing price. These RSUs vest 100% one year after the grant date.
On November 13, 2025, 392 shares were withheld to satisfy tax obligations related to previously granted RSUs at a price of $96.26. After the reported transactions, the director beneficially owned 19,836 shares, held directly.